A way to revive failed livers through stem cells could be available within the next few years as clinical tests of a new treatment regimen are underway. Pharmicell, a Korean pharmaceutical company developing stem cell therapeutics, said Monday that it has submitted a plan for the commercialization of “Livercellgram,” a stem cell therapy for liver failure, to the Korea Food and Drug Administration (KFDA).
View the original article here: Stem cells may cure liver failure – Korea Times
 |
Infographics | More... |
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
Viewpoint: Should you be concerned when you read that a chemical in your food has been linked to cancer? Here’s an epidemiologist’s checklist to detect over-hyped scares 
Viewpoint: By engineering block on Vitamin A enhanced Golden Rice, Greenpeace ‘puts the whole environmental movement into disrepute’ 
Viewpoint: Debunking organic food myths again… and again 
Why you may soon be shopping for tomatoes enhanced with snapdragon flower genes 
Viewpoint: Sri Lanka’s ‘tragic’ legacy — To encourage sustainable farming, countries cannot ignore food production and socioeconomic trade-offs 
How common is incest? Rise of genetic testing reveals disturbing evidence 
How Freddie Mercury got his voice: It wasn’t his teeth 
Hive coup? Why queen bees are sometimes killed by workers 
Does GMO corn increase crop yields? More than 20 years of data confirm it does — and provides substantial health and safety benefits 
